Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
Essy MozaffariAastha ChandakRobert L GottliebChidinma Chima-MeltonStephanie H ReadEunYoung LeeCeline Der-TorossianRikisha GuptaMark BerryStijn HollemeerschAndre C KalilPublished in: Open forum infectious diseases (2023)
Remdesivir treatment is associated with significantly reduced mortality among patients hospitalized for COVID-19 requiring supplemental oxygen upon admission, including those requiring HFO/NIV or IMV/ECMO with severe or critical disease, across VOC periods.
Keyphrases
- sars cov
- mechanical ventilation
- acute respiratory distress syndrome
- respiratory failure
- cardiovascular events
- respiratory syndrome coronavirus
- extracorporeal membrane oxygenation
- intensive care unit
- coronavirus disease
- risk factors
- emergency department
- copy number
- coronary artery disease
- gene expression
- cardiovascular disease
- dna methylation
- smoking cessation